FREMONT, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), today announced the launch of its new ...

Clear Labs announced its expanded automation platform and collaboration with Labcorp to develop streamlined, oncology-focused NGS workflows, marking its move beyond infectious disease sequencing and ...

Tempus AI advances its genomics push with new assays, CDx progress and plans for whole-genome sequencing to drive future growth.

Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced presentations demonstrating the clinical impact of using its flagship metagenomic ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

Alok Dadhich, Chief Business Officer of LifeCell Diagnostics, said "LifeCell envisions a future in which preventive healthcare is a way of life. Our mission is to make early and accurate diagnostics ...

Detailed price information for Creative Medical Technology Holdings Inc (CELZ-Q) from The Globe and Mail including charting and trades.

Sensus Healthcare, Inc. , a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, ...

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...